Search research articles
Contact Us
Filters
Showing results (361-370 of 411) with videos related to
Page
of 42
Sort By:
Frontiers in Cell and Developmental Biology
|
November 19, 2019
Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Ibrahim El-Battrawy, Jonas Müller, Zhihan Zhao, et al.
Cancers
|
June 2, 2021
Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients
Georg Lodde, Andrea Forschner, Jessica Hassel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2024
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
Lea Jessica Albrecht, Florentia Dimitriou, Piyush Grover, et al.
Nature Communications
|
June 1, 2017
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions
Antje Sucker, Fang Zhao, Natalia Pieper, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 22, 2025
Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma
Dirk Tomsitz, Elisabeth Livingstone, Carmen Loquai, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2022
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma
Ivelina Spassova, Selma Ugurel, Linda Kubat, et al.
Journal for Immunotherapy of Cancer
|
November 15, 2019
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Markus V Heppt, Teresa Amaral, Katharina C Kähler, et al.
Oncogene
|
July 12, 2018
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas
Manfred Kunz, Henry Löffler-Wirth, Michael Dannemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2025
Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma
Georg C Lodde, Jessica C Hassel, Imke von Wasielewski, et al.
Cancers
|
June 2, 2021
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study
Henner Stege, Maximilian Haist, Michael Schultheis, et al.
Page
of 42
Search research articles
Search
Showing results (361-370 of 411) with videos related to
Sort By:
Page
of 42
Frontiers in Cell and Developmental Biology
|
November 19, 2019
Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Ibrahim El-Battrawy, Jonas Müller, Zhihan Zhao, et al.
Cancers
|
June 2, 2021
Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients
Georg Lodde, Andrea Forschner, Jessica Hassel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2024
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
Lea Jessica Albrecht, Florentia Dimitriou, Piyush Grover, et al.
Nature Communications
|
June 1, 2017
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions
Antje Sucker, Fang Zhao, Natalia Pieper, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 22, 2025
Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma
Dirk Tomsitz, Elisabeth Livingstone, Carmen Loquai, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2022
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma
Ivelina Spassova, Selma Ugurel, Linda Kubat, et al.
Journal for Immunotherapy of Cancer
|
November 15, 2019
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Markus V Heppt, Teresa Amaral, Katharina C Kähler, et al.
Oncogene
|
July 12, 2018
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas
Manfred Kunz, Henry Löffler-Wirth, Michael Dannemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2025
Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma
Georg C Lodde, Jessica C Hassel, Imke von Wasielewski, et al.
Cancers
|
June 2, 2021
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study
Henner Stege, Maximilian Haist, Michael Schultheis, et al.
Page
of 42